The National Institutes of Health, a renowned biomedical research funder, faces potential upheaval under new leadership choices. Critics like Robert F. Kennedy, Jr. and Dr. Jay Bhattacharya aim to reshape the agency's focus, sparking concerns about the future of vital research and public health advancements.